Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Fixing DNA errors is crucial to prevent skin cancer.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Gefitinib can cause hair loss without scarring.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Gefitinib can cause hair and eyebrow darkening.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

The article concludes that while we understand a lot about how melanocytes age and how this can prevent cancer, there are still unanswered questions about certain pathways and genes involved.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

NFIB and STAT5 work together to control specific genetic programs in cells.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Foxp1 helps control hair stem cell growth and response to stress during hair growth cycles.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

EMT and metabolic pathways help cancer cells resist treatment and spread.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Nilotinib can cause generalized keratosis pilaris.

Erlotinib can cause nonscarring hair loss and itchy skin.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Krt6a-Cre transgenic mice help study gene effects on hair follicle development and tumor suppression.